DOC: CLINICAL GUIDELINES ON THE MANAGEMENT OF HEPATITIS C


Patients infected with hepatitis C virus (HCV) should be referred to a clinician with a particular interest in the infection. Patients must have access to adequate counselling from a health carer with knowledge and experience of chronic HCV infection. All patients must have access to the appropriate diagnostic and therapeutic options available in the management of HCV infection.... Document/File: .pdf, filesize: n/a. Filetype: pdf. Filename: clinical-guidelines-on-the-management-of-hepatitis-c. Title: Clinical guidelines on the management of hepatitis C. 2014.

 

File Info:

  • Filesize: N/A
  • Source: bsg_dot_org_dot_uk
  •   Date Archived: 2017-05-27
  •   Author: N/A
 
 
 
 
 

Related Files:

 

  RISK MANAGEMENT HANDBOOK

... THE INTERNATIONAL RISK MANAGEMENT STANDARD AS/NZS ISO 31000:2009 (THE STANDARD) PROVIDES THE PRINCIPLES AND GUIDELINES FOR RISK MANAGEMENT. ACCORDING TO THE STANDARD, THE SUCCESS OF RISK MANAGEMENT WILL DEPEND ON THE EFFECTIVENESS OF THE MANAGEMENT FRAMEWORK PROVIDING THE FOUNDATIONS AND ARRANGEMENTS THAT WILL EMBED IT THROUGHOUT THE ORGANISATION AT ALL LEVELS. ...
  risk-management-handbook     PDF     2017-05-26  
 

 

  HEPATITIS B IMMUNE GLOBULIN

... PREVENTS HEPATITIS B INFECTION INPATIENTS WHO ARE KNOWN TO HAVE BEEN EXPOSED, INCLUDING NEONATES BORN TO HBSAG-POSITIVE WOMEN, BY PROVIDING PASSIVE IMMUNITY. ACTION AN IMMUNE GAMMA-GLOBULIN FRACTION CONTAINING HIGH TITERS OF ANTIBODIES TO THE HEPATITIS B SURFACE ANTIGEN. CONFERS PASSIVE IMMUNITY TO HEPATITIS B INFECTION. THERAPEUTIC EFFECTS: PREVENTION OF HEPATITIS B INFECTION. ...
  hepatitis-b-immune-globulin     PDF     2017-05-27  
 

 

  GUIDELINE ON ANTERIOR CRUCIATE LIGAMENT INJURY

... THE DUTCH ORTHOPAEDIC ASSOCIATION HAS A LONG TRADITION OF DEVELOPMENT OF PRACTICAL CLINICAL GUIDELINES. HERE WE PRESENT THE RECOMMENDATIONS FROM THE MULTIDISCIPLINARY CLINICAL GUIDELINE WORKING GROUP FOR ANTERIOR CRUCIATE LIGAMENT INJURY. ...
  guideline-on-anterior-cruciate-ligament-injury     PDF     2017-05-27  
 

 

  EPIDEMIOLOGY AND PREVENTION OF HEPATITIS B VIRUS INFECTION

... HEPATITIS B IS ONE OF THE MOST COMMON INFECTIOUS DISEASES GLOBALLY. IT HAS BEEN ESTIMATED THAT THERE ARE 350 MILLION CHRONIC HEPATITIS B VIRUS (HBV) CARRIERS WORLDWIDE. THE PREVALENCE OF CHRONIC HBV INFECTION VARIES GEOGRAPHICALLY, FROM HIGH (>8%), INTERMEDIATE (2-7%) TO LOW (<2%) PREVALENCE. ...
  epidemiology-and-prevention-of-hepatitis-b-virus-infection     PDF     2017-05-28  
 

 

  CLINICAL GUIDELINES FOR STROKE MANAGEMENT

... ALL STROKE PATIENTS SHOULD BE MANAGED AS A TIME CRITICAL EMERGENCY. THE DISPATCH OF AMBULANCES TO SUSPECTED STROKE PATIENTS WHO MAY BE ELIGIBLE FOR REPERFUSION THERAPIES REQUIRES THE HIGHEST LEVEL OF PRIORITY. FURTHERMORE, THE HIGHEST LEVEL OF PRIORITY SHOULD ALSO BE PROVIDED WHEN TRANSPORTING SUSPECTED STROKE PATIENTS TO HOSPITALS CAPABLE OF OFFERING REPERFUSION THERAPIES WITHIN APPROPRIATE TIMEFRAMES. ...
  clinical-guidelines-for-stroke-management     PDF     2017-05-28  
 

 

  HEPATITIS B IMMUNE GLOBULIN (HUMAN)

... HEPATITIS B IMMUNE GLOBULIN (HUMAN) — HYPERHEPB® S/D TREATED WITH SOLVENT/DETERGENT IS A COLORLESS TO PALE YELLOW OR PINK STERILE SOLUTION OF HEPATITIS B HYPERIMMUNE IMMUNE GLOBULIN FOR INTRAMUSCULAR ADMINISTRATION; IT IS PRESERVATIVE-FREE AND LATEX-FRE ...
  hepatitis-b-immune-globulin-human     PDF     2017-05-27  
 

 

  HEPATITIS B VIRUS BIOLOGY

... HEPATITIS B VIRUS (HBV) CAUSES TRANSIENT AND CHRONIC INFECTIONS OF THE LIVER. TRANSIENT INFECTIONS MAY PRODUCE SERIOUS ILLNESS, AND APPROXIMATELY 0.5% TERMINATE WITH FATAL, FULMINANT HEPATITIS. CHRONIC INFECTIONS MAY ALSO HAVE SERIOUS CONSEQUENCES: NEARLY 25% TERMINATE IN UNTREATABLE LIVER CANCER (10). WORLDWIDE DEATHS FROM LIVER CANCER CAUSED BY HBV INFECTION PROBABLY EXCEED ONE MILLION PER YEAR (52, 162). ...
  hepatitis-b-virus-biology     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS: EPIDEMIOLOGY AND TRANSMISSION RISKS

... HEPATITIS B VIRUS (HBV) INFECTION IS A SERIOUS AND COMMON INFECTIOUS DISEASE OF THE LIVER, AFFECTING MILLIONS OF PEOPLE THROUGHOUT THE WORLD. THE INCUBATION PERIOD FOR HBV IS 45-180 DAYS, MOST COMMONLY 60-90 DAYS. ...
  hepatitis-b-virus-epidemiology-and-transmission-risks     PDF     2017-05-28  
 

 

  HEPATITIS B VIRUS REPLICATION AND INTEGRATION

... CHRONIC INFECTION WITH HEPATITIS B VIRUS (HBV) AFFECTS 240 MILLION PEOPLE WORLDWIDE AND MAY CAUSE LIVER DISEASE INCLUDING HEPATOCELLULAR CARCINOMA (HCC). INITIALLY PATIENTS HAVE HIGH LEVELS OF HBV DNA IN THEIR BLOOD, NO LIVER DISEASE AND EXPRESS THE E ANTIGEN (HBEAG). ...
  hepatitis-b-virus-replication-and-integration     PDF     2017-05-28  
 

 

  DACLATASVIR FOR TREATING CHRONIC HEPATITIS C

... DACLATASVIR IS RECOMMENDED AS AN OPTION FOR TREATING CHRONIC HEPATITIS C IN ADULTS, AS SPECIFIED IN TABLE 1, ONLY IF THE COMPAN Y PROVIDES DACLATASVIR AT THE SAME PRICE OR LOWER THAN THAT AGREED WITH THE COMMERCIAL MEDICINES UNIT. ...
  daclatasvir-for-treating-chronic-hepatitis-c     PDF     2017-05-27